BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 34524000)

  • 1. Novel Continuous Glucose Monitoring Metrics and Large-for-Gestational-Age Risk: An Exploratory Retrospective Cohort Study in Pregnancies with Type 1 Diabetes.
    Sibiak R; Gutaj P; Mrzewka-Rogacz B; Mantaj U; Wender-Ozegowska E
    Diabetes Technol Ther; 2022 Jan; 24(1):42-53. PubMed ID: 34524000
    [No Abstract]   [Full Text] [Related]  

  • 2. Continuous glucose monitoring parameters in pregnancy-related complications in patients with type 1 diabetes: a retrospective cohort study.
    Sibiak R; Mantaj U; Gutaj P; Zozulińska-Ziółkiewicz D; Wender-Ozegowska E
    Pol Arch Intern Med; 2023 Nov; 133(11):. PubMed ID: 37227218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of intermittently scanned continuous glucose monitoring to standard care in a cohort of pregnant women with type 1 diabetes: effect on glycaemic control and pregnancy outcomes.
    Perea V; Picón MJ; Megia A; Goya M; Wägner AM; Vega B; Seguí N; Montañez MD; Vinagre I
    Diabetologia; 2022 Aug; 65(8):1302-1314. PubMed ID: 35546211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous glucose monitoring metrics and pregnancy outcomes in insulin-treated diabetes: A post-hoc analysis of the GlucoMOMS trial.
    Rademaker D; van der Wel AWT; van Eekelen R; Voormolen DN; de Valk HW; Evers IM; Mol BW; Franx A; Siegelaar SE; van Rijn BB; DeVries JH; Painter RC;
    Diabetes Obes Metab; 2023 Dec; 25(12):3798-3806. PubMed ID: 37735847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin pump therapy with and without continuous glucose monitoring in pregnant women with type 1 diabetes: a prospective observational Orchestra Foundation study in Poland.
    Cypryk K; Wender-Ozegowska E; Cyganek K; Sieradzki J; Skoczylas K; Chen X; Cordero TL; Shin J; Cohen O
    Acta Diabetol; 2023 Apr; 60(4):553-561. PubMed ID: 36653533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analysis of daily glycemic profiles and excessive fetal growth in pregnant patients with well-controlled type 1 diabetes: Retrospective cohort.
    Sibiak R; Mantaj U; Gutaj P; Richard Law G; Wender-Ozegowska E
    Diabetes Res Clin Pract; 2024 Jan; 207():111088. PubMed ID: 38195042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between HbA1c and continuous glucose monitoring metrics of glycaemic control and glucose variability in a large cohort of children and adolescents with type 1 diabetes.
    Piona C; Marigliano M; Mozzillo E; Rosanio F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Piccinno E; Delvecchio M; Maffeis C
    Diabetes Res Clin Pract; 2021 Jul; 177():108933. PubMed ID: 34216681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.
    Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L
    Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous glucose monitoring and insulin pump therapy in pregnant women with type 1 diabetes mellitus.
    Lason I; Cyganek K; Witek P; Matejko B; Malecki MT; Skupien J
    Ginekol Pol; 2021; 92(10):675-681. PubMed ID: 33914316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of continuous glucose monitoring compared with self-monitoring of blood glucose in gestational diabetes patients with HbA1c<6%: a randomized controlled trial.
    Lai M; Weng J; Yang J; Gong Y; Fang F; Li N; Kang M; Xu X; Wang Y
    Front Endocrinol (Lausanne); 2023; 14():1174239. PubMed ID: 37152928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycemic variability and indices of glycemic control among pregnant women with type 1 diabetes (T1D) based on the use of continuous glucose monitoring share technology.
    Sklar J; Pyle L; Snell-Bergeon JK; Garcetti R; Joshee P; Demmitt JK; Polsky S
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8968-8974. PubMed ID: 34875947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous glucose monitoring metrics (Mean Glucose, time above range and time in range) are superior to glycated haemoglobin for assessment of therapeutic efficacy.
    Rodbard D
    Diabetes Obes Metab; 2023 Feb; 25(2):596-601. PubMed ID: 36314133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies.
    Kristensen K; Ögge LE; Sengpiel V; Kjölhede K; Dotevall A; Elfvin A; Knop FK; Wiberg N; Katsarou A; Shaat N; Kristensen L; Berntorp K
    Diabetologia; 2019 Jul; 62(7):1143-1153. PubMed ID: 30904938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Feasibility Study of Paired Continuous Glucose Monitoring Intrapartum and in the Newborn in Pregnancies Complicated by Type 1 Diabetes.
    Stewart ZA; Thomson L; Murphy HR; Beardsall K
    Diabetes Technol Ther; 2019 Jan; 21(1):20-27. PubMed ID: 30620640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous Glucose Monitoring Time-in-Range and HbA
    Tundidor D; Meek CL; Yamamoto J; Martínez-Bru C; Gich I; Feig DS; Murphy HR; Corcoy R;
    Diabetes Technol Ther; 2021 Oct; 23(10):710-714. PubMed ID: 33945304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous Glucose Monitoring in Pregnancy: Importance of Analyzing Temporal Profiles to Understand Clinical Outcomes.
    Scott EM; Feig DS; Murphy HR; Law GR;
    Diabetes Care; 2020 Jun; 43(6):1178-1184. PubMed ID: 32209645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
    Dicembrini I; Cosentino C; Monami M; Mannucci E; Pala L
    Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous glucose monitoring reduces pubertal hyperglycemia of type 1 diabetes.
    Nwosu BU; Yeasmin S; Ayyoub S; Rupendu S; Villalobos-Ortiz TR; Jasmin G; Parajuli S; Zahedi B; Zitek-Morrison E; Alonso LC; Barton BA
    J Pediatr Endocrinol Metab; 2020 Jul; 33(7):865-872. PubMed ID: 32634109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.